Annual Non Current Assets
$1.14 B
-$812.20 M-41.53%
31 December 2023
Summary:
Emergent BioSolutions annual long term assets is currently $1.14 billion, with the most recent change of -$812.20 million (-41.53%) on 31 December 2023. During the last 3 years, it has fallen by -$543.60 million (-32.22%). EBS annual non current assets is now -41.53% below its all-time high of $1.96 billion, reached on 31 December 2022.EBS Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$816.40 M
-$42.60 M-4.96%
30 September 2024
Summary:
Emergent BioSolutions quarterly long term assets is currently $816.40 million, with the most recent change of -$42.60 million (-4.96%) on 30 September 2024. Over the past year, it has dropped by -$355.90 million (-30.36%). EBS quarterly non current assets is now -58.26% below its all-time high of $1.96 billion, reached on 31 December 2022.EBS Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.5% | -30.4% |
| 3 y3 years | -32.2% | -53.5% |
| 5 y5 years | -28.9% | -50.0% |
EBS Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -41.5% | at low | -58.3% | at low |
| 5 y | 5 years | -41.5% | at low | -58.3% | at low |
| alltime | all time | -41.5% | +4080.0% | -58.3% | +2883.8% |
Emergent BioSolutions Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $816.40 M(-5.0%) |
| June 2024 | - | $859.00 M(-23.4%) |
| Mar 2024 | - | $1.12 B(-2.0%) |
| Dec 2023 | $679.50 M(-43.9%) | $1.14 B(-2.4%) |
| Sept 2023 | - | $1.17 B(-16.3%) |
| June 2023 | - | $1.40 B(-18.9%) |
| Mar 2023 | - | $1.73 B(-11.6%) |
| Dec 2022 | $1.21 B(-4.7%) | $1.96 B(+9.3%) |
| Sept 2022 | - | $1.79 B(+8.4%) |
| June 2022 | - | $1.65 B(-1.7%) |
| Mar 2022 | - | $1.68 B(-0.5%) |
| Dec 2021 | $1.27 B(+6.2%) | $1.69 B(-3.9%) |
| Sept 2021 | - | $1.76 B(+0.2%) |
| June 2021 | - | $1.75 B(+2.0%) |
| Mar 2021 | - | $1.72 B(+1.9%) |
| Dec 2020 | $1.20 B(+74.3%) | $1.69 B(+1.8%) |
| Sept 2020 | - | $1.66 B(-0.8%) |
| June 2020 | - | $1.67 B(+1.1%) |
| Mar 2020 | - | $1.65 B(+0.7%) |
| Dec 2019 | $686.20 M(+10.5%) | $1.64 B(+0.4%) |
| Sept 2019 | - | $1.63 B(+0.3%) |
| June 2019 | - | $1.63 B(+0.2%) |
| Mar 2019 | - | $1.63 B(+1.0%) |
| Dec 2018 | $620.80 M(+27.9%) | $1.61 B(+163.5%) |
| Sept 2018 | - | $610.48 M(+2.2%) |
| June 2018 | - | $597.58 M(+1.0%) |
| Mar 2018 | - | $591.82 M(+1.2%) |
| Dec 2017 | $485.40 M(-4.9%) | $584.80 M(+24.9%) |
| Sept 2017 | - | $468.17 M(+1.6%) |
| June 2017 | - | $460.74 M(-0.4%) |
| Mar 2017 | - | $462.47 M(+0.6%) |
| Dec 2016 | $510.22 M(-5.1%) | $459.89 M(+1.7%) |
| Sept 2016 | - | $452.03 M(-14.5%) |
| June 2016 | - | $528.42 M(+4.1%) |
| Mar 2016 | - | $507.74 M(+1.5%) |
| Dec 2015 | $537.41 M | $500.07 M(-0.6%) |
| Sept 2015 | - | $503.06 M(-0.9%) |
| June 2015 | - | $507.83 M(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $512.03 M(+1.1%) |
| Dec 2014 | $432.18 M(+58.2%) | $506.52 M(+4.3%) |
| Sept 2014 | - | $485.66 M(-1.2%) |
| June 2014 | - | $491.80 M(-0.9%) |
| Mar 2014 | - | $496.05 M(+40.3%) |
| Dec 2013 | $273.12 M(+3.7%) | $353.51 M(-2.2%) |
| Sept 2013 | - | $361.45 M(+17.6%) |
| June 2013 | - | $307.45 M(+2.0%) |
| Mar 2013 | - | $301.31 M(+0.1%) |
| Dec 2012 | $263.35 M(+3.5%) | $300.88 M(+4.8%) |
| Sept 2012 | - | $287.09 M(+1.1%) |
| June 2012 | - | $283.93 M(+3.2%) |
| Mar 2012 | - | $275.14 M(-5.9%) |
| Dec 2011 | $254.42 M(+4.5%) | $292.45 M(+5.9%) |
| Sept 2011 | - | $276.20 M(+2.2%) |
| June 2011 | - | $270.14 M(+5.9%) |
| Mar 2011 | - | $255.07 M(-0.7%) |
| Dec 2010 | $243.49 M(+25.6%) | $256.83 M(+65.3%) |
| Sept 2010 | - | $155.40 M(+2.7%) |
| June 2010 | - | $151.30 M(+0.0%) |
| Mar 2010 | - | $151.25 M(+0.3%) |
| Dec 2009 | $193.81 M(+26.8%) | $150.88 M(+24.3%) |
| Sept 2009 | - | $121.39 M(-1.0%) |
| June 2009 | - | $122.66 M(-12.3%) |
| Mar 2009 | - | $139.86 M(+1.3%) |
| Dec 2008 | $152.89 M(+5.9%) | $138.11 M(+2.0%) |
| Sept 2008 | - | $135.42 M(-1.8%) |
| June 2008 | - | $137.89 M(+2.9%) |
| Mar 2008 | - | $134.01 M(+3.7%) |
| Dec 2007 | $144.31 M(-2.1%) | $129.20 M(+8.2%) |
| Sept 2007 | - | $119.39 M(+11.2%) |
| June 2007 | - | $107.39 M(+7.2%) |
| Mar 2007 | - | $100.20 M(+10.2%) |
| Dec 2006 | $147.34 M(+149.2%) | $90.92 M(+23.5%) |
| Sept 2006 | - | $73.64 M(+78.7%) |
| Dec 2005 | $59.12 M(+41.8%) | $41.22 M(+50.6%) |
| Dec 2004 | $41.70 M(+752.5%) | $27.36 M |
| Dec 2002 | $4.89 M(-16.5%) | - |
| Dec 2001 | $5.85 M | - |
FAQ
- What is Emergent BioSolutions annual long term assets?
- What is the all time high annual non current assets for Emergent BioSolutions?
- What is Emergent BioSolutions annual non current assets year-on-year change?
- What is Emergent BioSolutions quarterly long term assets?
- What is the all time high quarterly non current assets for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly non current assets year-on-year change?
What is Emergent BioSolutions annual long term assets?
The current annual non current assets of EBS is $1.14 B
What is the all time high annual non current assets for Emergent BioSolutions?
Emergent BioSolutions all-time high annual long term assets is $1.96 B
What is Emergent BioSolutions annual non current assets year-on-year change?
Over the past year, EBS annual long term assets has changed by -$812.20 M (-41.53%)
What is Emergent BioSolutions quarterly long term assets?
The current quarterly non current assets of EBS is $816.40 M
What is the all time high quarterly non current assets for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly long term assets is $1.96 B
What is Emergent BioSolutions quarterly non current assets year-on-year change?
Over the past year, EBS quarterly long term assets has changed by -$355.90 M (-30.36%)